CA
NZ
UK
AU
IND
US
● Neuronetics offered a rare upbeat signal on an otherwise cautious tape, with STIM shares ticking higher as the maker of NeuroStar transcranial magnetic stimulation therapy pushes toward profitability.
● Headquartered in Piombino Dese near Padua, Stevanato traces its roots to a glassmakingBusinessfounded in 1949 and today spans two segments: Biopharmaceutical and Diagnostic Solutions, which supplies drug-containment and delivery products, and Engineering, which builds assembly and inspection machinery.
The company behind the HydraFacial treatment has spent the past two years working to stabilize aBusinessthat grew fast and then stumbled. Now trading as SkinHealth Systems Inc. (NASDAQ: SKIN) after rebranding from The Beauty Health Company in April 2026, the Nasdaq-listed aesthetics group is …
Behind a fractional uptick in one of the market's smallest biotechs sits an ambitious clinical bet: silencing one of oncology's most notorious drivers. Silexion Therapeutics Corp (NASDAQ: SLXN), a nano-cap developer of RNA-interference therapies, edged higher in its latest session even as itsMarket Valuesits …
After a long stretch as an over-the-counter name, SANUWAVE Health, Inc. (NASDAQ:SNWV) has spent 2026 navigating life as a Nasdaq-listed medical-device company, and the transition has come with turbulence. The advanced wound-care specialist has posted strong consumableDemandwhile grappling with reimbursement pressure that has weighed …
Spencer Pharmaceutical Inc. (OTC:SPPH) is a ticker that carries more history than substance. Quoted at essentially a hundredth of a cent with aMarket Valuein the low hundreds of dollars in the last closing session, SPPH is a dormant deep-penny name whose most notable legacy …
● With aMarket Valueof under $3 million and fewer than 600,000 shares outstanding, SciSparc sits at the extreme small end of the biotech spectrum, where even minor trades can swing the price.
ARS Pharmaceuticals, Inc (NASDAQ:SPRY) has become one of the more closely followed commercial-stage names in the allergy space, largely on the back of neffy, its needle-free epinephrine nasal spray. Yet the stock has come under pressure in recent weeks, sliding toward the low-$5 range …
A quoted jump of 25% sounds dramatic until you see the numbers behind it: a move from a fraction of a cent to another fraction of a cent in a stock whose company is being wound down. That is the reality of Sorrento Therapeutics, …
Surgical-robotics upstart SS Innovations International (NASDAQ:SSII) has been one of the more talked-about medical-technology growth stories of 2026, so even a fractional daily pullback draws scrutiny. After a powerful run built on boomingDemandfor its SSi Mantra surgical robot, the shares eased modestly in recent …
Please wait processing your request...